Planet Briefing

First published · Last updated

Immunohistochemical and Molecular Biomarkers in Diffuse Large B-Cell Lymphoma: A Systematic Review of Diagnostic, Prognostic, and Therapeutic Implications

A posted systematic review evaluates protein- and genetic-level biomarkers used to diagnose, predict outcomes, and guide treatment in diffuse large B‑cell lymphoma. The item is posted content published by Springer Science and Business Media LLC on 2026-09-29.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
6/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
3/10
Positivity
6/10
Urgency
1/10

Why it matters

The review synthesizes evidence about biomarkers with potential diagnostic, prognostic, and therapeutic relevance for this lymphoma.

Sources

Report an issue